We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Bpo9.0
Benzoyl Peroxide Research
Mostly mechanism / observationalModerate safety
6 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Benzoyl Peroxide studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality meta-analyses and randomised trials published 2005–2025 with a typical study size of 517 participants.
Based on 6 studies · 1 meta-analysis · 2 RCTs · 1,210 total participants
Confidence
Moderate
By outcome
Endurance & exercise performance
Too few graded studies1 study
Women's health
Too few graded studies1 study
Safety profile
Too few graded studies1 study
Skin healthSignificant reduction in inflammatory and comedonal acne lesions (frontline OTC acne drug); best combined with a retinoid · 4-12 weeks
Too few graded studies1 study
Steady research
1 study in the last 5 years · Latest meta-analysis: 2025
200520152025
1Systematic Review2020
Current evidence suggests that BPO as monotherapy or add-on treatment may be more effective than placebo or no treatment for improving acne, and there may be little to no difference between BPO and either adapalene or clindamycin.
Yang Z, Zhang Y, Lazic Mosler E, Hu J, Li H, Zhang Y, Liu J, Zhang Q. · Cochrane Database Syst Rev (2020)
Pooled 120 RCTs (29,592 participants); BPO more effective than placebo/no treatment for participant-reported improvement (RR 1.27, 95% CI 1.12 to 1.45)
Little to no difference between BPO and adapalene (RR 0.99) or clindamycin (RR 0.95)
Withdrawal due to adverse effects higher with BPO (RR 2.13); most common were erythema, pruritus, and burning
The fixed-dose combination gel of adapalene and BPO was significantly more effective than corresponding monotherapies, with significant differences in total lesion counts observed as early as 1 week.
Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, Liu Y, Graeber M, Kang S; Adapalene-BPO Study Group. · J Am Acad Dermatol (2007)
Pivotal 12-week double-blind RCT (n=517) of adapalene-BPO vs adapalene, BPO, or vehicle
The fixed combination was significantly more effective than either monotherapy, separating by week 1
Tolerability matched adapalene monotherapy — synergy without added irritation
Topical antimicrobial therapies performed at least as well as oral antibiotics in terms of clinical efficacy. Benzoyl peroxide was the most cost-effective and minocycline the least cost-effective therapy for facial acne.
Ozolins M, Eady EA, Avery A, Cunliffe WJ, O'Neill C, Simpson NB, Williams HC. · Health Technol Assess (2005)
Assessor-blind community RCT (n=649) in mild-to-moderate inflammatory facial acne over 18 weeks
5% BPO performed at least as well as oral oxytetracycline/minocycline and was the most cost-effective regimen
No regimen increased antibiotic-resistant strains; BPO caused more local irritation than comparators